Work

Cost-Effectiveness of Adjuvant Therapy for Stage IIIA Melanoma Is Poor Even When Patients Are Risk-Stratified by Gene Expression Profile

Year: 2019

Type: article

Source: Journal of the American College of Surgeons

DOI: 10.1016/j.jamcollsurg.2019.08.770

Authors: Yinin Hu, Andrew Briggs, Michael Marchetti, Daniel Coit, Edmund Bartlett

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2981807008

FWCI:

Cites:

Cited by:

Related to: 10